Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders

This publication has 95 references indexed in Scilit:

• Use of 2-[18f]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) imaging for the evaluation of muscle metabolic activity in ruptured rotator cuffs: identification of shoulder muscles by fusion imaging studies involving both FDG PET and magnetic resonance imaging
  Journal of Shoulder and Elbow Surgery, 2003
• Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI
  European Journal of Nuclear Medicine and Molecular Imaging, 2003
• FDG-PET imaging of lower extremity muscular activity during level walking
  Journal of Orthopaedic Science, 2003
• Promising Role of 18-F-Fluoro-D-Deoxyglucose Positron Emission Tomography in Clinical Infectious Diseases
  European Journal of Clinical Microbiology & Infectious Diseases, 2002
• 18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factors
  Seminars in Nuclear Medicine, 2002
• Normal Thymic Uptake of FDG on PET Imaging
  Clinical Nuclear Medicine, 1996
• Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions
  Seminars in Nuclear Medicine, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• The use of 2-[18F]fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992